Monovisc 88 MG/4 ML syringe 4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG1XZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,485
Award facts
- Contract value 100% obligated
- $16,485.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,485.47 for Monovisc 88 mg/4 mL syringes on December 5, 2025, with completion expected by December 8, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. Monovisc is a viscosupplement used for osteoarthritis treatment, reflecting the types of specialized pharmaceutical products that AmerisourceBergen routinely supplies through its federal medical procurement agreements.
This delivery order is a child contract issued under AmerisourceBergen's prime IDC with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen's federal contracting portfolio demonstrates significant capability in supplying a broad spectrum of medications, medical devices, and healthcare commodities to military and veteran healthcare systems. The company's consistent receipt of competitively awarded, non-set-aside contracts underscores its established position as a critical vendor within the Defense Health Agency's pharmaceutical supply chain, serving customers across military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FG1XZ?
SPE2DR26FG1XZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FG1XZ worth?
The government has obligated $16,485 on SPE2DR26FG1XZ.
Is contract SPE2DR26FG1XZ an order under another contract?
Yes. SPE2DR26FG1XZ is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1XZ competed?
The extent of competition for SPE2DR26FG1XZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award